Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The absence of miR-21 resulted in the reduced expression of Ki67 and the attenuated proliferation of tumour cells with a simultaneous increase in E-cadherin and decrease in β-catenin and SOX9 in the tumours of CAC mice.
|
25994220 |
2016 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Increased expression of beta-catenin is a contributing cause of most familial and spontaneous human colon cancer and the cause of multiple intestinal neoplasia of the Apc(Min/+) mouse.
|
19106159 |
2009 |
Colon Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although activating mutations in the genes for adenomatous polyposis coli (APC) and beta-catenin are clearly associated with colon cancer, less is understood about the role of the upstream secreted ligands (Wnts) and their receptors (frizzled, Fz) in this process.
|
12147710 |
2002 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
HGUE-C-1 represents a novel and peculiar colon carcinoma model to study chemoresistance to chemotherapeutic agents and to novel anti-neoplasic drugs that interrupt signalling pathways such as the APC/βcatenin, Ras/Raf/Mek/Erk, PI3K/mTOR/p70S6K pathways as well as histone regulation mechanisms.
|
25885658 |
2015 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
|
10201372 |
1999 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.
|
28916833 |
2017 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The different sensitivities of PDX tumors to HI-B1 were dependent on the β-catenin expression level and potentially could be further exploited for biomarker development and therapeutic applications against colon cancer.
|
29033371 |
2017 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data suggest that ART1 could regulate EMT by regulating the RhoA/ROCK1/AKT/β-catenin pathway and its downstream factors (snail1, vimentin, N-cadherin and E-cadherin) and that it therefore plays an important role in the progression of colon carcinoma.
|
27277835 |
2016 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.
|
19790197 |
2010 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Examination of colon cancer tissues from patients revealed a correlation between elevated expression levels of USP4 and β-catenin.
|
26189775 |
2015 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Up-regulation of SND1 may thus occur at a very early stage in colon carcinogenesis and contribute to the posttranscriptional regulation of key players in colon cancer development, including APC and beta-catenin.
|
17909068 |
2007 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The selective ERα antagonist could significantly decrease Wnt2b/LRP8/Dvl1 expression, increase destruction complex (Axin2/GSK3a/APC) expression, and promote degradation of β-catenin in colon carcinoma cell by inhibited NLRP3 expression.
|
31121307 |
2019 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We treated Apc(Min/+) mice and carcinogen-induced colon cancer model C57BL/6 mice with T0070907 and counted the number of spontaneous polyps and aberrant crypt foci and observed cell proliferation and beta-catenin protein in the colon epithelium.
|
19075513 |
2008 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The effects of PER2 on cell proliferation and beta-catenin were studied in colon cancer cell lines by its down-regulation following RNA interference.
|
19010825 |
2008 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of β-catenin was elevated in T cells, including Tregs, of patients with colon cancer.
|
24574339 |
2014 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Conversely, siRNA knockdown of β1Pix attenuated both LiCl-induced β-catenin transcriptional activity and colon cancer cell proliferation.
|
24129564 |
2013 |
Colon Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We thus speculated whether SIRT1, known to target β-catenin in a colon cancer model, suppresses β-catenin in those pancreatic cancer cells that express PAUF (Panc-PAUF).
|
22640743 |
2012 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
TNF-induced apoptosis was also attenuated in human colon cancer cell lines with genetically activated β-catenin.
|
23339186 |
2013 |
Colon Carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Galectin-3 levels correlated with beta-catenin levels in a variety of colon cancer cell lines.
|
19190323 |
2009 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Colon cancer cells secrete and express high levels of β-catenin, which may stimulate autocrine signaling and further enhance activities of the canonical Wnt signaling pathway.
|
29808797 |
2018 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Patients' primary colon cancer tumours shown to express the same mut β-catenin allele also expressed high ABCB1 levels.
|
22460269 |
2012 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
VM-positive colon cancer samples showed increased Wnt3a expression (p < 0.001) and β-catenin nuclear expression (p < 0.001) compared with the VM-negative samples.
|
26266404 |
2015 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Using genetic approaches, studies in human colon cancers and Drosophila have identified CDK8 as a colon cancer oncogene that regulates beta-catenin transcriptional activity.
|
19808961 |
2009 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Nonsteroidal antiinflammatory drugs reverse aberrant beta-catenin expression and localization in colon cancer.
|
20470206 |
2010 |
Colon Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These data suggest that the down-regulation of β-catenin by genistein may constitute an important determinant of the suppression of HT-29 cell growth and may be exploited for the prevention and treatment of colon cancer.
|
24390805 |
2014 |